Security key
03770N101
Apogee Therapeutics, Inc. - Common Stock (APGE)
CUSIP: 03770N101
Q4 2025 13F Holders as of 31 Dec 2025
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 69,771,331
- Total 13F value
- $5,266,434,045
- Share change
- +9,434,359
- Put/Call ratio
- 43%
- SEC-reported price per share
- $75.48
- Number of holders
- 206
- Value change
- +$762,006,154
- Number of buys
- 130
- Number of sells
- 63
- Shares outstanding
- 62,702,889
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2025
Institutions
206
Top holders
10
APGE full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
Apogee Therapeutics, Inc. SEC filings
Apogee Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 03770N101
Recent filing periods:
Ownership snapshot
Top reported holders of APGE - Apogee Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BlackRock, Inc.
Disclosed value leader
Venrock Adviser, LLC
Comparable rows
15/15
Latest evidence
31 Dec 2025
13D/G
13F
Lead comparable stake: 5.5%
13D/G row: BlackRock, Inc.
Showing 1-6 of 15 holder rows.
Quick read
BlackRock, Inc. leads the comparable SEC ownership view at 5.5%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BlackRock, Inc.'s linked filing trail.
Comparable ownership
Top 5
BlackRock, Inc.
5.5%
RTW INVESTMENTS, LP
4.9%
DRIEHAUS CAPITAL MANAGEMENT LLC
4.7%
Venrock Adviser, LLC
14%
FMR LLC
11%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BlackRock, Inc. |
13D/G
13F
Company
|
5.5%
|
$109,396,539
2,518,725 shares
|
$0 | 30 Jun 2025 |
| RTW INVESTMENTS, LP |
13D/G
13F
Company
|
4.9%
|
$214,255,663
2,712,097 shares
|
$0 | 31 Dec 2025 |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13D/G
13F
Company
|
4.7%
|
$85,757,284
2,158,502 shares
|
$0 | 30 Sep 2025 |
| Venrock Adviser, LLC |
13F
Company
|
14%
|
$337,439,643
8,493,321 shares
|
— | 30 Sep 2025 |
| FMR LLC |
13F
Company
|
11%
|
$274,791,036
6,916,462 shares
|
— | 30 Sep 2025 |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
Company
|
7.5%
|
$187,672,640
4,723,701 shares
|
— | 30 Sep 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
206
Shares
69,771,331
Rows available
206
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
173
Q4 2025 holders
206
Holder diff
33
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 value | Q4 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend